1995
DOI: 10.1097/00001756-199512150-00004
|View full text |Cite
|
Sign up to set email alerts
|

Melatonin inhibits oxytocin and vasopressin release from the neurointermediate lobe of the hamster pituitary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

1996
1996
2016
2016

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 0 publications
1
13
0
Order By: Relevance
“…1A) and OT ( Fig. 2A) release from the H-NH system, which accords with previous results obtained when rat hypothalamus [11] or hamster neurointermediate lobe [13] were incubated in vitro. Melatonin, at a concentration of 10 -11 M, remained inactive in influencing the AVP and OT output from isolated rat H-NH complex (Fig.…”
Section: Discussionsupporting
confidence: 92%
See 3 more Smart Citations
“…1A) and OT ( Fig. 2A) release from the H-NH system, which accords with previous results obtained when rat hypothalamus [11] or hamster neurointermediate lobe [13] were incubated in vitro. Melatonin, at a concentration of 10 -11 M, remained inactive in influencing the AVP and OT output from isolated rat H-NH complex (Fig.…”
Section: Discussionsupporting
confidence: 92%
“…Melatonin, at a concentration of 10 -11 M, remained inactive in influencing the AVP and OT output from isolated rat H-NH complex (Fig. 1A and 2A) or rat hypothalamus [11], but when hamster neurointermediate lobe was incubated in vitro, the three concentrations of melatonin (10 -11 , 10 -9 and 10 -7 M) induced inhibitory effects of similar magnitude on OT and AVP release [13]. What is more, the highest concentration of melatonin used in our present experiments, i.e.…”
Section: Discussionmentioning
confidence: 88%
See 2 more Smart Citations
“…Several factors, which play a role as neuromediators and/or neuromodulators in the central nervous system, were found to influence this hormone secretion [1][2][3][4]. One of these factors is melatonin, which is able to modify OT secretion under different physiological and pathological conditions both in vivo [5][6] and in vitro [7][8][9][10][11]. The results, however, have shown that melatonin has either a stimulatory or an inhibitory effect, or is without influence on OT secretion, according to its concentration, the time of the day, animal species, and tissue sample (hypothalamus or neurohypophysis, or hypothalamo-neurohypophysial system) incubated in vitro.…”
Section: Introductionmentioning
confidence: 99%